Dr. Taylor M. Ortiz
Claim this profileFranciscan Health Indianapolis
Studies Breast Cancer
Studies Cancer
8 reported clinical trials
22 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 positive
ER positive
2Cancer
Stage IV
Stage III
HER2 negative
Affiliated Hospitals
Clinical Trials Taylor M. Ortiz is currently running
Epoetin Alfa vs Luspatercept
for Myelodysplastic Syndrome
This trial is testing two treatments, Luspatercept and epoetin alfa, to see which is better for treating anemia in adults with certain types of myelodysplastic syndromes (MDS). The participants have not used similar treatments before and do not need regular blood transfusions. Luspatercept helps red blood cells mature, while epoetin alfa increases their production.
Recruiting2 awards Phase 3
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
More about Taylor M. Ortiz
Clinical Trial Related2 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Taylor M. Ortiz has experience with
- Carboplatin
- Paclitaxel
- Epoetin Alfa
- Luspatercept
- Fulvestrant
- Placebo
Breakdown of trials Taylor M. Ortiz has run
Breast Cancer
Cancer
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Taylor M. Ortiz specialize in?
Taylor M. Ortiz focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Taylor M. Ortiz currently recruiting for clinical trials?
Yes, Taylor M. Ortiz is currently recruiting for 4 clinical trials in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Taylor M. Ortiz has studied deeply?
Yes, Taylor M. Ortiz has studied treatments such as Carboplatin, Paclitaxel, Epoetin Alfa.
What is the best way to schedule an appointment with Taylor M. Ortiz?
Apply for one of the trials that Taylor M. Ortiz is conducting.
What is the office address of Taylor M. Ortiz?
The office of Taylor M. Ortiz is located at: Franciscan Health Indianapolis, Indianapolis, Indiana 46237 United States. This is the address for their practice at the Franciscan Health Indianapolis.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.